Patent 8613717
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Active provider: Google · gemini-2.5-pro
No PTAB proceedings on file. This patent has not been challenged through Inter Partes Review, Post-Grant Review, or Covered Business Method review at the USPTO. The absence is itself a signal — well-asserted patents eventually attract IPRs.
Cases on file (1)
Group view →Specific litigation cases in our database that name US patent 8613717. The free-form analysis below may also discuss cases beyond this list.
- Angiodynamics Inc v. Endovascular Engineering Incfiled Apr 23, 20261:26-cv-00469Delaware District CourtOpen
Defendants: Endovascular Engineering Inc
Other patents asserted: 11589880, 12496077
The lawsuit targets the Viper and Cobra catheters and their associated medical system for removing blood clots. This system includes a pump, a blood/clot collection device, and other related components.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
As of April 26, 2026, U.S. Patent No. 8,613,717 is involved in one known litigation case.
AngioDynamics, Inc. v. Endovascular Engineering, Inc.
- Plaintiff(s): AngioDynamics, Inc.
- Defendant(s): Endovascular Engineering, Inc. (also known as E2)
- Jurisdiction: U.S. District Court for the District of Delaware
- Case Number: 1:26-cv-00469
- Filing Date: April 23, 2026
- Status: Active/Open
- Details: AngioDynamics, Inc. has filed a lawsuit alleging that Endovascular Engineering's Hēlo Thrombectomy System infringes on several of its patents, including US Patent 8,613,717. The complaint focuses on the alleged unauthorized use of AngioDynamics' proprietary self-expanding funnel technology, which is designed to improve the removal of thrombi and emboli. AngioDynamics is seeking unspecified damages, which may include lost profits and a reasonable royalty, as well as preliminary and permanent injunctions to prevent further infringement. The company has stated its intent to vigorously protect its intellectual property. This lawsuit is notable for AngioDynamics investors as it represents a significant effort to defend its market position in thrombectomy devices. In addition to the '717 patent, the suit also asserts infringement of U.S. Patent Nos. 11,589,880 and 12,496,077.
Generated 5/1/2026, 10:44:40 PM